Therapeutic advantages of droloxifene, a new antiestrogen, in breast cancer, Hamburg FRG, August 18, 1990PRITCHARD, Kathleen I; ROCHEFORT, Henri.American journal of clinical oncology. 1991, Vol 14, issn 0277-3732, 70 p., SUP2Conference Proceedings

Droloxifene, a new antiestrogen, in advanced breast cancer : a double-blind dose-finding studyDESCHENES, L.American journal of clinical oncology. 1991, Vol 14, pp S52-S55, issn 0277-3732, SUP2Conference Paper

Mechanism of action of high-affinity antiestrogens : an overviewROCHEFORT, H.American journal of clinical oncology. 1991, Vol 14, pp S1-S4, issn 0277-3732, SUP2Conference Paper

Cardiovascular health and aromatase inhibitorsPRITCHARD, Kathleen I; ABRAMSON, Beth L.Drugs (Basel). 2006, Vol 66, Num 13, pp 1727-1740, issn 0012-6667, 14 p.Article

Droloxifene, a new antiestrogen : hormonal influences in postmenopausal breast cancer patientsKVINNSLAND, S.American journal of clinical oncology. 1991, Vol 14, pp S46-S51, issn 0277-3732, SUP2Conference Paper

Japanese early phase II study of droloxifene in the treatment of advanced breast cancer : preliminary dose-finding studyABE, O.American journal of clinical oncology. 1991, Vol 14, pp S40-S45, issn 0277-3732, SUP2Conference Paper

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancerDENT, Susan F; GASPO, Rania; KISSNER, Michelle et al.Breast cancer research and treatment. 2011, Vol 126, Num 2, pp 295-310, issn 0167-6806, 16 p.Article

European early phase II dose-finding study of droloxifene in advanced breast cancerBELLMUNT, J; SOLE, L.American journal of clinical oncology. 1991, Vol 14, pp S36-S39, issn 0277-3732, SUP2Conference Paper

Pharmacokinetics of droloxifene and its metabolites in breast cancer patientsGRILL, H. J; POLLOW, K.American journal of clinical oncology. 1991, Vol 14, pp S21-S29, issn 0277-3732, SUP2Conference Paper

Pharmacologic and biologic properties of droloxifene, a new antiestrogenEPPENBERGER, U; WOSIKOWSKI, K; KÜNG, W et al.American journal of clinical oncology. 1991, Vol 14, pp S5-S14, issn 0277-3732, SUP2Conference Paper

Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast CancerGOODWIN, Pamela J; ENNIS, Marguerite; PRITCHARD, Kathleen I et al.Journal of clinical oncology. 2009, Vol 27, Num 23, pp 3757-3763, issn 0732-183X, 7 p.Article

HER2/neu in systemic therapy for women with breast cancer : a systematic reviewDHESY-THIND, Bindi; PRITCHARD, Kathleen I; MESSERSMITH, Hans et al.Breast cancer research and treatment. 2008, Vol 109, Num 2, pp 209-229, issn 0167-6806, 21 p.Article

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III TrialGOSS, Paul E; INGLE, James N; D'SOUZA, David P et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1398-1404, issn 0732-183X, 7 p.Article

Health-Related Quality of Life of Patients With Advanced Breast Cancer Treated With Everolimus Plus Exemestane Versus Placebo Plus Exemestane in the Phase 3, Randomized, Controlled, BOLERO-2 TrialBURRIS, Howard A; LEBRUN, Fabienne; CHOUINARD, Edmond et al.Cancer. 2013, Vol 119, Num 10, pp 1908-1915, issn 0008-543X, 8 p.Article

Health-related quality of life and disease symptoms in postmenopausal women with HR⁺, HER2^― advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapyCAMPONE, Mario; THADDEUS BECK, J; NUNZI, Martina et al.Current medical research and opinion. 2013, Vol 29, Num 11, pp 1463-1473, issn 0300-7995, 11 p.Article

TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patientsHERTEL, Pernille Braemer; DONGSHENG TU; BRÜNNER, Nils et al.Breast cancer research and treatment. 2012, Vol 132, Num 1, pp 225-234, issn 0167-6806, 10 p.Article

Elevated Bone Turnover Predicts for Bone Metastasis in Postmenopausal Breast Cancer: Results of NCIC CTG MA.14LIPTON, Allan; CHAPMAN, Judy-Anne W; DEMERS, Laurence et al.Journal of clinical oncology. 2011, Vol 29, Num 27, pp 3605-3610, issn 0732-183X, 6 p.Article

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk ReductionVISVANATHAN, Kala; CHLEBOWSKI, Rowan T; ARUN, Banu et al.Journal of clinical oncology. 2009, Vol 27, Num 19, pp 3235-3258, issn 0732-183X, 24 p.Article

Cancer Treatment-Induced Bone Loss in Breast and Prostate CancerSAAD, Fred; ADACHI, Jonathan D; BROWN, Jacques P et al.Journal of clinical oncology. 2008, Vol 26, Num 33, pp 5465-5476, issn 0732-183X, 12 p.Article

Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer : Update of national cancer institute of Canada clinical trials group trial MA5LEVINE, Mark N; PRITCHARD, Kathleen I; BRAMWELL, Vivien H. C et al.Journal of clinical oncology. 2005, Vol 23, Num 22, pp 5166-5170, issn 0732-183X, 5 p.Article

A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancerRAKOVITCH, Eileen; FRANSSEN, Edmee; KIM, John et al.Breast cancer research and treatment. 2003, Vol 77, Num 3, pp 285-293, issn 0167-6806, 9 p.Article

Randomized Trial of Decongestive Lymphatic Therapy for the Treatment of Lymphedema in Women With Breast CancerDAYES, Ian S; WHELAN, Tim J; MANCHUL, Lee et al.Journal of clinical oncology. 2013, Vol 31, Num 30, pp 3758-3763, issn 0732-183X, 6 p.Article

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized TrialCHEANG, Maggie C. U; DAVID VODUC, K; STIJLEMAN, Inge J et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2402-2412, issn 1078-0432, 11 p.Article

Lymphedema in women with breast cancer : characteristics of patients screened for a randomized trialDAYES, Ian S; LEVINE, Mark N; JULIAN, J. A et al.Breast cancer research and treatment. 2008, Vol 110, Num 2, pp 337-342, issn 0167-6806, 6 p.Article

Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer : NCIC MA.16CRUMP, Michael; GLUCK, Stefan; GIROUARD, Caroline et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 37-43, issn 0732-183X, 7 p.Article